IBERE PHARMACEUTICALS Quarterly Assets in USD from Q4 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Ibere Pharmaceuticals quarterly Assets history and growth rate from Q4 2020 to Q3 2022.
Ibere Pharmaceuticals Assets for the quarter ending September 30, 2022 was $139M, a 0.02% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$139M	-$28.8K	-0.02%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$138M	-$830K	-0.6%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$138M	-$1.28M	-0.92%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$139M	+$138M	+20408%	Dec 31, 2021	10-Q	2022-11-14
Q3 2021	$139M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$139M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$140M			Mar 31, 2021	10-Q/A	2021-08-16
Q4 2020	$676K			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.